Continuous intravertebral injection of fasudil hydrochloride in the treatment of cerebral vasospasm

Neurology India

Volumn 59, Issue 2, 2011, Pages 161-167

  Liu, Peng ^a   Liao, Xuxing ^b   Xiang, Jianwei ^c   Pan, Li ^c   Ma, Lianting ^c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

^c WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Cerebral vasospasm; continuous intravertebral artery injection; fasudil hydrochloride; subarachnoid hemorrhage

Indexed keywords

FASUDIL;

ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN VASOSPASM; CONTINUOUS INFUSION; CONTROL GROUP; CONTROLLED STUDY; ELECTRON MICROSCOPY; NONHUMAN; RABBIT; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION; VERTEBROBASILAR ANGIOGRAPHY;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; INJECTIONS, INTRA-ARTERIAL; RABBITS; TREATMENT OUTCOME; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 79955460989     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.79127     Document Type: Article

References (32)

1. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med 2006;355:928-39. (Pubitemid 44321760)
2. Al-Yamany M, Wallace MC. Management of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Intensive Care Med 1999;25:1463-6.
3. Biller J, Godersky JC Jr, Adams HP. Management of aneurysmal subarachnoid hemorrhage. Stroke 1988;19:1300-5.
4. Sen J, Belli A, Albon H, Morgan L, Petzold A, Kitchen N. Triple-H therapy in the management of aneurismal subarachnoid haemorrhage. Lancet Neurol 2003;2:614-21.
5. Porchet F, Chiolero R, de Tribolet N. Hypotensive effect of nimodipine during treatment for aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 1995;137:62-9.
6. Stiefel MF, Heuer GG, Abrahams JM, Bloom S, Smith MJ, Maloney- Wilensky E, et al. The effect of nimodipine on cerebral oxygenation in patients with poor-grade subarachnoid hemorrhage. J Neurosurg 2004;101:594-9. (Pubitemid 43186416)
7. Subramani K, Ghrew M. Severe myocardial depression following intravenous nimodipine for aneurysmal subarachnoid haemorrhage. Intensive Care Med 2004;30:1498-9. (Pubitemid 38951741)
8. Megyesi JF, Vollrath B, Cook DA, Findlay JM. In vivo animal models of cerebral vasospasm: A review. Neurosurgery 2000;46:448-60.
9. Yanamoto H, Kikuchi H, Okamoto S, Nozaki K. Cerebral vasospasm caused by cisternal injection of polystyrene latex beads in rabbits is inhibited by a serine protease inhibitor. Surg Neurol 1994;42:3742-81.
10. Ma LT, He DH. The experimental study of curative effects of papverine and nimodipine on cerebral vasospasm. J Jinan University (Natur Sci) 2002;21:105-8.
11. Touho H, Karasawa J, Ohnishi H, Ueda S. Selective angiography of the vertebral artery in the rabbit: Technical note. Surg Neurol 1996;46:84-6. (Pubitemid 26225495)
12. Shi ZS, Huang ZS, Guo SL. Selective angiography of the vertebral artery in rabbitmodel of cerebral vasospasm. J Apply Nerve Dis 2003;20:532-4.
13. Endo S, Branson PJ, Alksne JF. Experimental model of symptomatic vasospasm in rabbits. Stroke 1988;19:1420-5.
14. Marbacher S, Neuschmelting V, Graupner T, Jakob SM, Fandino J. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo. Intensive Care Med 2008;34:932-8. (Pubitemid 351571198)
15. Dorsch NW. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Crit Care 2002;8:128-33.
16. Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16: 562-72. (Pubitemid 15007226)
17. Treggiari-Venzi MM, Suter PM, Romand JA. Review of medical prevention of vasospasm after aneurysmal subarachnoid hemorrhage: A problem of neurointensive care. Neurosurgery 2001;48:249-62. (Pubitemid 32164863)
18. Barker FG II, Ogilvy CS. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A meta-analysis. J Neurosurg 1996;84:405-14. (Pubitemid 26062864)
19. Haley EC Jr, Kassell NF, Torner JC, Truskowski LL, Germanson TP. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage: A report of the Cooperative Aneurysm Study. J Neurosurg 1994;80:788-96. (Pubitemid 24129672)
20. Oskouian RJ Jr, Martin NA, Lee JH, Glenn TC, Guthrie D, Gonzalez NR, et al. Multimodal quantitation of the effects of endovascular therapy for vasospasm on cerebral blood flow, transcranial Doppler ultrasonographic velocities, and cerebral artery diameters. Neurosurgery 2002;51:30-41.
21. Bejjani GK, Bank WO, Olan WJ, Sekhar LN. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 1998;42:979-87. (Pubitemid 28196508)
22. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, et al. Balloon angioplasty for the treatment of vasospasm: Results of first 50 cases. Neurosurgery 1998;42:510-7. (Pubitemid 28128736)
23. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 1992;77: 842-7.
24. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2000;92:284-90. (Pubitemid 30071048)
25. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intraarterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery 1998;42:1256-67. (Pubitemid 28264858)
26. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol 1995;16: 27-38.
27. Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg 1992;77:848-52.
28. Masaoka H, Takasato Y, Nojiri T, Hayakawa T, Akimoto H, Yatsushige H, et al. Clinical effect of fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage. Acta Neurochir Suppl 2001;77:209-11. (Pubitemid 33759249)
29. Shibuya M, Asano T, Sasaki Y. Effect of fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm. Acta Neurochir Suppl (Wien) 2001;77:201-4. (Pubitemid 33759247)
30. Nagumo H, Sasaki Y, Ono Y, Okamoto H, Seto M, Takuwa Y. Kinase inhibitor HA-1077 prevents mediated myosin phosphatase inhibition in smooth muscle cells. Am J Physiol Cell Physiol 2000;278:C57-65. (Pubitemid 30101895)
31. Tachibana E, Harada T, Shibuya M. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien) 1999;141:13-9. (Pubitemid 29062727)
32. Tanaka K, Minami H, Kota M. Treatment of cerebral vasospasm with intra-arterial fasudil hydrochloride. Neurosurgery 2005;56:214-23.